학술논문

Impact of cemiplimab on quality of life (QoL), functioning and symptoms in patients (pts) with recurrent/metastatic (R/M) cervical carcinoma: Results from EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9
Document Type
Journal
Source
ANNALS OF ONCOLOGY; 2021, 32 pS755-pS756, 2p. Supplement: 5
Subject
Language
English
ISSN
15698041